Screener
Nektar Therapeutics NKTR Q1 2025 earnings
Reported May 8, 2025 · After market close
Revenue$10.5MMiss by $4.9M
EPS-$3.30Miss by $0.60
Revenue estimate$15.4M
EPS estimate-$2.70
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$10.4M
EPS estimate-$2.13
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Nektar Therapeutics report Q1 2025 earnings?
- Nektar Therapeutics (NKTR) reported Q1 2025 earnings on May 8, 2025 after market close.
- What were Nektar Therapeutics's Q1 2025 revenue and EPS?
- Nektar Therapeutics reported revenue of $10.5M and eps of $-3.30 for Q1 2025.
- Did Nektar Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $15.4M by $4.9M. EPS missed the consensus estimate of $-2.70 by $0.60.
- How did Nektar Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 51.7% from $21.6M a year earlier and eps declined 1733.3% from $-0.18.
- Where can I find Nektar Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-041085) and the 10-Q periodic report (0000950170-25-067279) directly on SEC EDGAR. The filing index links above go to sec.gov.
